newsfilter
← Latest News
ACCESS Newswire·

Wellgistics Health to Add Telehealth & Mental Health AI Capabilities via Tollo Health Partnership Expansion

WGRX
  • Wellgistics Health (NASDAQ: WGRX) expanded its partnership with Tollo Health to integrate TolloCare, a wholly-owned subsidiary focused on telehealth, mental health AI, & public health information.
  • TolloCare was initially established to provide telehealth services for GLP-1 & Long COVID patients but will now expand to support Wellgistics' emerging partnership with NFL Alumni Health.
  • TolloCare utilizes white-labeled telehealth capabilities via a platform with over 5,000 onboarded physicians to deliver synchronous & asynchronous medical services including prescriptions for weight loss.
  • TolloCare entered an agreement with a stealth San Francisco Bay Area startup to deploy a mental health AI app designed to engage patients & improve outcomes.
  • TolloCare intends to expand its service focus to include mental health, weight loss maintenance after GLP-1 discontinuation, cardiometabolic disease, sleep apnea, & pain management.
  • Wellgistics aims to leverage Tollo Health's intellectual capital on essential amino acids to educate physicians & pharmacists on using GLP-1 agonist drugs in conjunction with its Forzet product.
  • The expanded partnership aligns with Wellgistics' strategic shift from pharmaceutical distribution-only to comprehensive patient services through its Wellgistics Pharmacy Network & online pharmacy.
  • Forzet distribution is scheduled to begin in the current quarter, coinciding with the availability of more convenient oral GLP-1 formulations.